Jefferies cuts Bright Minds Biosciences price target to $110 from $145
DRUG•Jefferies cut its price target for Bright Minds Biosciences to $110 from $145.
Related News
Apogee Enterprises offers CEO Nolan transition bonus of up to $250,000
APOG•
US stock index futures rise after oil drop and recent equity selloff
SPY•
Grifols announces EUR 0.15 per share interim dividend
GRFS•
AllianceBernstein sees recovery potential in undervalued healthcare stocks
XLV•
Dollar declines ahead of US midterms as oil falls; bitcoin steadies after crypto theft
SPY•